nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprenolol—Acebutolol—hypertension	0.0631	0.175	CrCtD
Alprenolol—ADRB1—hypertension	0.0628	0.543	CbGaD
Alprenolol—Metoprolol—hypertension	0.0573	0.159	CrCtD
Alprenolol—Esmolol—hypertension	0.0543	0.151	CrCtD
Alprenolol—Pindolol—hypertension	0.053	0.147	CrCtD
Alprenolol—ADRB2—hypertension	0.0528	0.457	CbGaD
Alprenolol—Penbutolol—hypertension	0.0518	0.144	CrCtD
Alprenolol—Betaxolol—hypertension	0.0478	0.133	CrCtD
Alprenolol—Propranolol—hypertension	0.0325	0.0902	CrCtD
Alprenolol—ADRB3—Labetalol—hypertension	0.0167	0.0684	CbGbCtD
Alprenolol—ADRB3—Nadolol—hypertension	0.0167	0.0684	CbGbCtD
Alprenolol—ADRB3—Pindolol—hypertension	0.0142	0.0582	CbGbCtD
Alprenolol—ADRB2—Esmolol—hypertension	0.00898	0.0369	CbGbCtD
Alprenolol—ADRB1—Esmolol—hypertension	0.00885	0.0363	CbGbCtD
Alprenolol—ADRB3—Timolol—hypertension	0.00813	0.0334	CbGbCtD
Alprenolol—ADRB3—Carvedilol—hypertension	0.00788	0.0324	CbGbCtD
Alprenolol—Methocarbamol—Carvedilol—hypertension	0.00734	0.03	CrCrCtD
Alprenolol—ADRB3—Propranolol—hypertension	0.00725	0.0298	CbGbCtD
Alprenolol—ADRB2—Nebivolol—hypertension	0.00681	0.028	CbGbCtD
Alprenolol—ADRB2—Nadolol—hypertension	0.00681	0.028	CbGbCtD
Alprenolol—ADRB2—Labetalol—hypertension	0.00681	0.028	CbGbCtD
Alprenolol—ADRB1—Nebivolol—hypertension	0.00671	0.0275	CbGbCtD
Alprenolol—ADRB1—Nadolol—hypertension	0.00671	0.0275	CbGbCtD
Alprenolol—ADRB1—Labetalol—hypertension	0.00671	0.0275	CbGbCtD
Alprenolol—Penbutolol—Nadolol—hypertension	0.00629	0.0257	CrCrCtD
Alprenolol—ADRB2—Acebutolol—hypertension	0.00623	0.0256	CbGbCtD
Alprenolol—ADRB1—Acebutolol—hypertension	0.00613	0.0252	CbGbCtD
Alprenolol—Guaifenesin—Carvedilol—hypertension	0.006	0.0245	CrCrCtD
Alprenolol—ADRB2—Pindolol—hypertension	0.00579	0.0238	CbGbCtD
Alprenolol—ADRB2—Metoprolol—hypertension	0.00579	0.0238	CbGbCtD
Alprenolol—ADRB1—Pindolol—hypertension	0.0057	0.0234	CbGbCtD
Alprenolol—ADRB1—Metoprolol—hypertension	0.0057	0.0234	CbGbCtD
Alprenolol—Metipranolol—Acebutolol—hypertension	0.00554	0.0226	CrCrCtD
Alprenolol—HTR1A—Nebivolol—hypertension	0.00537	0.022	CbGbCtD
Alprenolol—Penbutolol—Timolol—hypertension	0.00535	0.0218	CrCrCtD
Alprenolol—ADRB2—Betaxolol—hypertension	0.00516	0.0212	CbGbCtD
Alprenolol—ADRB1—Betaxolol—hypertension	0.00508	0.0209	CbGbCtD
Alprenolol—Metipranolol—Metoprolol—hypertension	0.00503	0.0205	CrCrCtD
Alprenolol—Metipranolol—Esmolol—hypertension	0.00477	0.0195	CrCrCtD
Alprenolol—ADRB2—Penbutolol—hypertension	0.00472	0.0194	CbGbCtD
Alprenolol—Betaxolol—Acebutolol—hypertension	0.00472	0.0193	CrCrCtD
Alprenolol—Metipranolol—Pindolol—hypertension	0.00465	0.019	CrCrCtD
Alprenolol—Guaifenesin—Pindolol—hypertension	0.00465	0.019	CrCrCtD
Alprenolol—ADRB1—Penbutolol—hypertension	0.00465	0.0191	CbGbCtD
Alprenolol—HTR1A—Pindolol—hypertension	0.00456	0.0187	CbGbCtD
Alprenolol—Guaifenesin—Penbutolol—hypertension	0.00455	0.0186	CrCrCtD
Alprenolol—Bisoprolol—Acebutolol—hypertension	0.0044	0.018	CrCrCtD
Alprenolol—Acebutolol—Metoprolol—hypertension	0.00428	0.0175	CrCrCtD
Alprenolol—Betaxolol—Metoprolol—hypertension	0.00428	0.0175	CrCrCtD
Alprenolol—Betaxolol—Esmolol—hypertension	0.00406	0.0166	CrCrCtD
Alprenolol—Acebutolol—Esmolol—hypertension	0.00406	0.0166	CrCrCtD
Alprenolol—Bisoprolol—Metoprolol—hypertension	0.00399	0.0163	CrCrCtD
Alprenolol—Acebutolol—Pindolol—hypertension	0.00396	0.0162	CrCrCtD
Alprenolol—Betaxolol—Pindolol—hypertension	0.00396	0.0162	CrCrCtD
Alprenolol—Oxprenolol—Acebutolol—hypertension	0.00389	0.0159	CrCrCtD
Alprenolol—Metoprolol—Acebutolol—hypertension	0.00389	0.0159	CrCrCtD
Alprenolol—Practolol—Acebutolol—hypertension	0.00389	0.0159	CrCrCtD
Alprenolol—Bisoprolol—Esmolol—hypertension	0.00379	0.0155	CrCrCtD
Alprenolol—Pindolol—Nadolol—hypertension	0.00378	0.0154	CrCrCtD
Alprenolol—HTR1A—Penbutolol—hypertension	0.00372	0.0153	CbGbCtD
Alprenolol—Bisoprolol—Pindolol—hypertension	0.0037	0.0151	CrCrCtD
Alprenolol—Atenolol—Acebutolol—hypertension	0.00368	0.015	CrCrCtD
Alprenolol—Acebutolol—Betaxolol—hypertension	0.00357	0.0146	CrCrCtD
Alprenolol—Oxprenolol—Metoprolol—hypertension	0.00353	0.0144	CrCrCtD
Alprenolol—Practolol—Metoprolol—hypertension	0.00353	0.0144	CrCrCtD
Alprenolol—Esmolol—Acebutolol—hypertension	0.00349	0.0143	CrCrCtD
Alprenolol—Methocarbamol—Propranolol—hypertension	0.00348	0.0142	CrCrCtD
Alprenolol—Oxprenolol—Esmolol—hypertension	0.00335	0.0137	CrCrCtD
Alprenolol—Practolol—Esmolol—hypertension	0.00335	0.0137	CrCrCtD
Alprenolol—Metoprolol—Esmolol—hypertension	0.00335	0.0137	CrCrCtD
Alprenolol—Atenolol—Metoprolol—hypertension	0.00334	0.0136	CrCrCtD
Alprenolol—Bisoprolol—Betaxolol—hypertension	0.00333	0.0136	CrCrCtD
Alprenolol—Pindolol—Acebutolol—hypertension	0.00333	0.0136	CrCrCtD
Alprenolol—ADRB2—Timolol—hypertension	0.00332	0.0137	CbGbCtD
Alprenolol—ADRB1—Timolol—hypertension	0.00327	0.0135	CbGbCtD
Alprenolol—Metoprolol—Pindolol—hypertension	0.00327	0.0133	CrCrCtD
Alprenolol—Oxprenolol—Pindolol—hypertension	0.00327	0.0133	CrCrCtD
Alprenolol—Practolol—Pindolol—hypertension	0.00327	0.0133	CrCrCtD
Alprenolol—ADRB2—Carvedilol—hypertension	0.00322	0.0132	CbGbCtD
Alprenolol—Oxprenolol—Penbutolol—hypertension	0.00319	0.013	CrCrCtD
Alprenolol—Esmolol—Metoprolol—hypertension	0.00317	0.013	CrCrCtD
Alprenolol—ADRB1—Carvedilol—hypertension	0.00317	0.013	CbGbCtD
Alprenolol—Atenolol—Esmolol—hypertension	0.00317	0.0129	CrCrCtD
Alprenolol—Atenolol—Pindolol—hypertension	0.00309	0.0126	CrCrCtD
Alprenolol—Pindolol—Metoprolol—hypertension	0.00302	0.0123	CrCrCtD
Alprenolol—ADRB2—Propranolol—hypertension	0.00296	0.0122	CbGbCtD
Alprenolol—Oxprenolol—Betaxolol—hypertension	0.00295	0.012	CrCrCtD
Alprenolol—Metoprolol—Betaxolol—hypertension	0.00295	0.012	CrCrCtD
Alprenolol—Practolol—Betaxolol—hypertension	0.00295	0.012	CrCrCtD
Alprenolol—HTR1A—Prazosin—hypertension	0.00294	0.0121	CbGbCtD
Alprenolol—Esmolol—Pindolol—hypertension	0.00294	0.012	CrCrCtD
Alprenolol—ADRB1—Propranolol—hypertension	0.00292	0.012	CbGbCtD
Alprenolol—Pindolol—Esmolol—hypertension	0.00287	0.0117	CrCrCtD
Alprenolol—Penbutolol—Propranolol—hypertension	0.00285	0.0116	CrCrCtD
Alprenolol—Guaifenesin—Propranolol—hypertension	0.00285	0.0116	CrCrCtD
Alprenolol—Metipranolol—Propranolol—hypertension	0.00285	0.0116	CrCrCtD
Alprenolol—Atenolol—Betaxolol—hypertension	0.00279	0.0114	CrCrCtD
Alprenolol—Esmolol—Betaxolol—hypertension	0.00265	0.0108	CrCrCtD
Alprenolol—Pindolol—Betaxolol—hypertension	0.00252	0.0103	CrCrCtD
Alprenolol—Acebutolol—Propranolol—hypertension	0.00243	0.00991	CrCrCtD
Alprenolol—Betaxolol—Propranolol—hypertension	0.00243	0.00991	CrCrCtD
Alprenolol—Propranolol—Carvedilol—hypertension	0.00235	0.00961	CrCrCtD
Alprenolol—HTR1A—Propranolol—hypertension	0.00234	0.0096	CbGbCtD
Alprenolol—Bisoprolol—Propranolol—hypertension	0.00226	0.00924	CrCrCtD
Alprenolol—Propranolol—Acebutolol—hypertension	0.00217	0.00887	CrCrCtD
Alprenolol—Metoprolol—Propranolol—hypertension	0.002	0.00817	CrCrCtD
Alprenolol—Oxprenolol—Propranolol—hypertension	0.002	0.00817	CrCrCtD
Alprenolol—Practolol—Propranolol—hypertension	0.002	0.00817	CrCrCtD
Alprenolol—Propranolol—Metoprolol—hypertension	0.00197	0.00805	CrCrCtD
Alprenolol—Atenolol—Propranolol—hypertension	0.00189	0.00773	CrCrCtD
Alprenolol—Propranolol—Esmolol—hypertension	0.00187	0.00764	CrCrCtD
Alprenolol—Propranolol—Pindolol—hypertension	0.00182	0.00745	CrCrCtD
Alprenolol—Esmolol—Propranolol—hypertension	0.0018	0.00734	CrCrCtD
Alprenolol—Propranolol—Penbutolol—hypertension	0.00178	0.00728	CrCrCtD
Alprenolol—Pindolol—Propranolol—hypertension	0.00171	0.00699	CrCrCtD
Alprenolol—CYP2D6—Labetalol—hypertension	0.00171	0.00701	CbGbCtD
Alprenolol—CYP2D6—Nebivolol—hypertension	0.00171	0.00701	CbGbCtD
Alprenolol—Propranolol—Betaxolol—hypertension	0.00165	0.00672	CrCrCtD
Alprenolol—CYP2D6—Acebutolol—hypertension	0.00156	0.00641	CbGbCtD
Alprenolol—CYP2D6—Pindolol—hypertension	0.00145	0.00596	CbGbCtD
Alprenolol—CYP2D6—Metoprolol—hypertension	0.00145	0.00596	CbGbCtD
Alprenolol—CYP2D6—Betaxolol—hypertension	0.00129	0.00532	CbGbCtD
Alprenolol—CYP2D6—Doxazosin—hypertension	0.00114	0.00468	CbGbCtD
Alprenolol—CYP2D6—Diltiazem—hypertension	0.0011	0.00452	CbGbCtD
Alprenolol—CYP2D6—Bepridil—hypertension	0.000981	0.00403	CbGbCtD
Alprenolol—CYP2D6—Irbesartan—hypertension	0.000897	0.00368	CbGbCtD
Alprenolol—CYP2D6—Amlodipine—hypertension	0.00088	0.00361	CbGbCtD
Alprenolol—CYP2D6—Felodipine—hypertension	0.000848	0.00348	CbGbCtD
Alprenolol—CYP2D6—Timolol—hypertension	0.000834	0.00343	CbGbCtD
Alprenolol—CYP2D6—Nifedipine—hypertension	0.00082	0.00337	CbGbCtD
Alprenolol—CYP2D6—Nicardipine—hypertension	0.000808	0.00332	CbGbCtD
Alprenolol—CYP2D6—Carvedilol—hypertension	0.000808	0.00332	CbGbCtD
Alprenolol—CYP2D6—Propranolol—hypertension	0.000743	0.00305	CbGbCtD
Alprenolol—CYP2D6—Captopril—hypertension	0.000734	0.00302	CbGbCtD
Alprenolol—CYP2D6—Clonidine—hypertension	0.000709	0.00291	CbGbCtD
Alprenolol—CYP2D6—Atorvastatin—hypertension	0.000632	0.0026	CbGbCtD
Alprenolol—CYP2D6—Verapamil—hypertension	0.00051	0.0021	CbGbCtD
Alprenolol—ADRB2—Treprostinil—Nadolol—hypertension	0.000456	1	CbGdCrCtD
Alprenolol—Practolol—ADRB1—hypertension	9.22e-05	0.0674	CrCbGaD
Alprenolol—Metipranolol—ADRB1—hypertension	8.34e-05	0.061	CrCbGaD
Alprenolol—Metipranolol—ADRB2—hypertension	7.02e-05	0.0513	CrCbGaD
Alprenolol—Esmolol—ADRB1—hypertension	6.63e-05	0.0484	CrCbGaD
Alprenolol—Penbutolol—HTR1B—hypertension	6.54e-05	0.0478	CrCbGaD
Alprenolol—Betaxolol—ADRB1—hypertension	5.83e-05	0.0427	CrCbGaD
Alprenolol—Penbutolol—ADRB1—hypertension	5.78e-05	0.0423	CrCbGaD
Alprenolol—Atenolol—ADRB1—hypertension	5.78e-05	0.0423	CrCbGaD
Alprenolol—Bisoprolol—ADRB1—hypertension	5.64e-05	0.0412	CrCbGaD
Alprenolol—Esmolol—ADRB2—hypertension	5.57e-05	0.0407	CrCbGaD
Alprenolol—Acebutolol—ADRB1—hypertension	5.34e-05	0.039	CrCbGaD
Alprenolol—Oxprenolol—ADRB1—hypertension	5.3e-05	0.0387	CrCbGaD
Alprenolol—Betaxolol—ADRB2—hypertension	4.91e-05	0.0359	CrCbGaD
Alprenolol—Penbutolol—ADRB2—hypertension	4.86e-05	0.0355	CrCbGaD
Alprenolol—Atenolol—ADRB2—hypertension	4.86e-05	0.0355	CrCbGaD
Alprenolol—Bisoprolol—ADRB2—hypertension	4.74e-05	0.0346	CrCbGaD
Alprenolol—Pindolol—HTR1B—hypertension	4.71e-05	0.0344	CrCbGaD
Alprenolol—Metoprolol—ADRB1—hypertension	4.51e-05	0.0329	CrCbGaD
Alprenolol—Acebutolol—ADRB2—hypertension	4.49e-05	0.0328	CrCbGaD
Alprenolol—Oxprenolol—ADRB2—hypertension	4.46e-05	0.0326	CrCbGaD
Alprenolol—Pindolol—ADRB1—hypertension	4.17e-05	0.0305	CrCbGaD
Alprenolol—Metoprolol—ADRB2—hypertension	3.79e-05	0.0277	CrCbGaD
Alprenolol—Pindolol—ADRB2—hypertension	3.51e-05	0.0256	CrCbGaD
Alprenolol—Propranolol—HTR1B—hypertension	2.57e-05	0.0188	CrCbGaD
Alprenolol—Propranolol—CYP3A5—hypertension	2.42e-05	0.0177	CrCbGaD
Alprenolol—Propranolol—ADRB1—hypertension	2.27e-05	0.0166	CrCbGaD
Alprenolol—Propranolol—ADRB2—hypertension	1.91e-05	0.014	CrCbGaD
Alprenolol—Propranolol—CYP1A1—hypertension	1.64e-05	0.012	CrCbGaD
Alprenolol—ADRB1—Signaling Pathways—RPS6KB1—hypertension	1.4e-06	4.06e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PDGFRB—hypertension	1.4e-06	4.06e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—EDN1—hypertension	1.39e-06	4.04e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ALDH2—hypertension	1.39e-06	4.04e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ADCY5—hypertension	1.38e-06	4.01e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCL5—hypertension	1.38e-06	4.01e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—LPL—hypertension	1.38e-06	4.01e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MTOR—hypertension	1.38e-06	4e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PRKCG—hypertension	1.38e-06	3.98e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—H2AFX—hypertension	1.37e-06	3.98e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—RPS6KB1—hypertension	1.37e-06	3.97e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PDGFRB—hypertension	1.37e-06	3.97e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ITGB3—hypertension	1.37e-06	3.96e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PRKCA—hypertension	1.37e-06	3.96e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—HBA1—hypertension	1.36e-06	3.93e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—YWHAZ—hypertension	1.36e-06	3.93e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ADCY5—hypertension	1.35e-06	3.92e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—LPL—hypertension	1.35e-06	3.92e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP11A1—hypertension	1.35e-06	3.91e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PRKCG—hypertension	1.35e-06	3.9e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—H2AFX—hypertension	1.34e-06	3.89e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PDGFRB—hypertension	1.34e-06	3.88e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—RPS6KB1—hypertension	1.34e-06	3.88e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SPP1—hypertension	1.34e-06	3.88e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NGF—hypertension	1.34e-06	3.88e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PRKCA—hypertension	1.34e-06	3.87e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ITGB3—hypertension	1.34e-06	3.87e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CXCL8—hypertension	1.33e-06	3.86e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CXCL8—hypertension	1.33e-06	3.85e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTT1—hypertension	1.33e-06	3.84e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SLC9A1—hypertension	1.33e-06	3.84e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—YWHAZ—hypertension	1.33e-06	3.84e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ADCY5—hypertension	1.32e-06	3.84e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PRKCG—hypertension	1.32e-06	3.81e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NGF—hypertension	1.31e-06	3.8e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SPP1—hypertension	1.31e-06	3.8e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GCLC—hypertension	1.31e-06	3.8e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CETP—hypertension	1.31e-06	3.8e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ITGB3—hypertension	1.31e-06	3.79e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PRKCA—hypertension	1.31e-06	3.79e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CXCL8—hypertension	1.3e-06	3.78e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PRKCD—hypertension	1.3e-06	3.78e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCR5—hypertension	1.3e-06	3.78e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—YWHAZ—hypertension	1.3e-06	3.75e-05	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—AKT1—hypertension	1.28e-06	3.72e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NGF—hypertension	1.28e-06	3.71e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SPP1—hypertension	1.28e-06	3.71e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CXCL8—hypertension	1.28e-06	3.7e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HTR2A—hypertension	1.28e-06	3.7e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PRKCD—hypertension	1.28e-06	3.69e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCR5—hypertension	1.28e-06	3.69e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—C3—hypertension	1.27e-06	3.69e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—IL6—hypertension	1.26e-06	3.66e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP17A1—hypertension	1.25e-06	3.64e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HTR2A—hypertension	1.25e-06	3.61e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PRKCD—hypertension	1.25e-06	3.61e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCR5—hypertension	1.25e-06	3.61e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—C3—hypertension	1.25e-06	3.61e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ENO1—hypertension	1.24e-06	3.6e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PTGS1—hypertension	1.24e-06	3.6e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PDGFB—hypertension	1.24e-06	3.59e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—FGFR1—hypertension	1.23e-06	3.57e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HTR2A—hypertension	1.22e-06	3.53e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—C3—hypertension	1.22e-06	3.53e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HIF1A—hypertension	1.21e-06	3.52e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PDGFB—hypertension	1.21e-06	3.51e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—AGT—hypertension	1.21e-06	3.51e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—FGFR1—hypertension	1.21e-06	3.49e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MMP9—hypertension	1.2e-06	3.48e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CDKN1A—hypertension	1.2e-06	3.47e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CTGF—hypertension	1.2e-06	3.46e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PTEN—hypertension	1.19e-06	3.46e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CALM1—hypertension	1.19e-06	3.45e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HIF1A—hypertension	1.19e-06	3.44e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PDGFB—hypertension	1.19e-06	3.44e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APOE—hypertension	1.19e-06	3.44e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—LEP—hypertension	1.19e-06	3.44e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—HMGCR—hypertension	1.19e-06	3.43e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GOT2—hypertension	1.19e-06	3.43e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—AGT—hypertension	1.18e-06	3.43e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—FGFR1—hypertension	1.18e-06	3.42e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CAV1—hypertension	1.17e-06	3.4e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APOA1—hypertension	1.17e-06	3.4e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MAPK8—hypertension	1.17e-06	3.38e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—AKT1—hypertension	1.16e-06	3.37e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CALM1—hypertension	1.16e-06	3.37e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HIF1A—hypertension	1.16e-06	3.37e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—KDR—hypertension	1.16e-06	3.37e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APOE—hypertension	1.16e-06	3.36e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—LEP—hypertension	1.16e-06	3.36e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ADRA2A—hypertension	1.16e-06	3.36e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AGT—hypertension	1.16e-06	3.35e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CAV1—hypertension	1.15e-06	3.33e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APOA1—hypertension	1.15e-06	3.32e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—EP300—hypertension	1.14e-06	3.3e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CALM1—hypertension	1.14e-06	3.3e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—KDR—hypertension	1.14e-06	3.29e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APOE—hypertension	1.13e-06	3.29e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—LEP—hypertension	1.13e-06	3.29e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CAV1—hypertension	1.12e-06	3.26e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APOA1—hypertension	1.12e-06	3.25e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—FN1—hypertension	1.12e-06	3.24e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PRKCB—hypertension	1.12e-06	3.24e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—F2—hypertension	1.12e-06	3.24e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—KDR—hypertension	1.11e-06	3.22e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—SRC—hypertension	1.11e-06	3.21e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NOTCH1—hypertension	1.09e-06	3.17e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—F2—hypertension	1.09e-06	3.17e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—FN1—hypertension	1.09e-06	3.17e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PRKCB—hypertension	1.09e-06	3.17e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—TH—hypertension	1.09e-06	3.15e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CALM2—hypertension	1.08e-06	3.13e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—VEGFA—hypertension	1.08e-06	3.12e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NOTCH1—hypertension	1.07e-06	3.1e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—FN1—hypertension	1.07e-06	3.1e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—F2—hypertension	1.07e-06	3.1e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PRKCB—hypertension	1.07e-06	3.1e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GCG—hypertension	1.06e-06	3.06e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SLC2A4—hypertension	1.06e-06	3.06e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NOTCH1—hypertension	1.05e-06	3.03e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GOT1—hypertension	1.02e-06	2.96e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—POMC—hypertension	1.02e-06	2.95e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—INS—hypertension	1.01e-06	2.93e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCL2—hypertension	9.97e-07	2.89e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—POMC—hypertension	9.97e-07	2.89e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP19A1—hypertension	9.93e-07	2.88e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—STK11—hypertension	9.93e-07	2.88e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MYC—hypertension	9.92e-07	2.87e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—INS—hypertension	9.91e-07	2.87e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TGFB1—hypertension	9.9e-07	2.87e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IGF1—hypertension	9.8e-07	2.84e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—AKT2—hypertension	9.79e-07	2.84e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—EGFR—hypertension	9.75e-07	2.82e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCL2—hypertension	9.75e-07	2.82e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—POMC—hypertension	9.74e-07	2.82e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—EGFR—hypertension	9.7e-07	2.81e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—INS—hypertension	9.69e-07	2.81e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IGF1—hypertension	9.59e-07	2.78e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—AKT2—hypertension	9.58e-07	2.77e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—EGFR—hypertension	9.54e-07	2.76e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCL2—hypertension	9.53e-07	2.76e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IGF1—hypertension	9.37e-07	2.72e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AKT2—hypertension	9.37e-07	2.71e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—EGFR—hypertension	9.33e-07	2.7e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SERPINE1—hypertension	9.31e-07	2.7e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—COMT—hypertension	9.23e-07	2.67e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PPARGC1A—hypertension	9.1e-07	2.64e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GNB3—hypertension	9.1e-07	2.64e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SERPINE1—hypertension	9.1e-07	2.64e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—HMOX1—hypertension	9.06e-07	2.63e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—FGF2—hypertension	9.01e-07	2.61e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—RHOA—hypertension	8.98e-07	2.6e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CAT—hypertension	8.94e-07	2.59e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SERPINE1—hypertension	8.9e-07	2.58e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NOS3—hypertension	8.88e-07	2.57e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PIK3R1—hypertension	8.88e-07	2.57e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GNAS—hypertension	8.86e-07	2.57e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—FGF2—hypertension	8.81e-07	2.55e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—RHOA—hypertension	8.78e-07	2.54e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NOS3—hypertension	8.69e-07	2.52e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PIK3R1—hypertension	8.69e-07	2.52e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOB—hypertension	8.68e-07	2.51e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—FGF2—hypertension	8.62e-07	2.5e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—RHOA—hypertension	8.59e-07	2.49e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NOS3—hypertension	8.5e-07	2.46e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PIK3R1—hypertension	8.5e-07	2.46e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTM1—hypertension	8.44e-07	2.45e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—RELA—hypertension	8.36e-07	2.42e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—LPL—hypertension	8.29e-07	2.4e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MTOR—hypertension	8.2e-07	2.38e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—RELA—hypertension	8.18e-07	2.37e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TP53—hypertension	8.15e-07	2.36e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ADCY5—hypertension	8.11e-07	2.35e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GPX1—hypertension	8.09e-07	2.34e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MTOR—hypertension	8.02e-07	2.32e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PRKCA—hypertension	8e-07	2.32e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP1A1—hypertension	8e-07	2.32e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—RELA—hypertension	8e-07	2.32e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CXCL8—hypertension	7.88e-07	2.28e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CD36—hypertension	7.88e-07	2.28e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MTOR—hypertension	7.84e-07	2.27e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CXCL8—hypertension	7.71e-07	2.23e-05	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—AKT1—hypertension	7.61e-07	2.21e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CXCL8—hypertension	7.54e-07	2.18e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL6—hypertension	7.49e-07	2.17e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—MTHFR—hypertension	7.46e-07	2.16e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL6—hypertension	7.46e-07	2.16e-05	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—AKT1—hypertension	7.45e-07	2.16e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL6—hypertension	7.33e-07	2.12e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PPARA—hypertension	7.32e-07	2.12e-05	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—AKT1—hypertension	7.28e-07	2.11e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL6—hypertension	7.17e-07	2.08e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MMP9—hypertension	7.13e-07	2.06e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CDKN1A—hypertension	7.1e-07	2.06e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—AGT—hypertension	7.09e-07	2.05e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PTEN—hypertension	7.09e-07	2.05e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MMP9—hypertension	6.97e-07	2.02e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CALM1—hypertension	6.97e-07	2.02e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CDKN1A—hypertension	6.95e-07	2.01e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOE—hypertension	6.95e-07	2.01e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MAPK8—hypertension	6.93e-07	2.01e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PTEN—hypertension	6.93e-07	2.01e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—AKT1—hypertension	6.91e-07	2e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CAV1—hypertension	6.88e-07	1.99e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—AKT1—hypertension	6.88e-07	1.99e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOA1—hypertension	6.87e-07	1.99e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MMP9—hypertension	6.82e-07	1.97e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CDKN1A—hypertension	6.79e-07	1.97e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MAPK8—hypertension	6.78e-07	1.96e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PTEN—hypertension	6.78e-07	1.96e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—AKT1—hypertension	6.76e-07	1.96e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—EP300—hypertension	6.76e-07	1.96e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MAPK8—hypertension	6.63e-07	1.92e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—AKT1—hypertension	6.61e-07	1.92e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—EP300—hypertension	6.61e-07	1.91e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SRC—hypertension	6.57e-07	1.9e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—EP300—hypertension	6.46e-07	1.87e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SRC—hypertension	6.43e-07	1.86e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—VEGFA—hypertension	6.4e-07	1.85e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SRC—hypertension	6.29e-07	1.82e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—VEGFA—hypertension	6.26e-07	1.81e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—VEGFA—hypertension	6.12e-07	1.77e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PPARG—hypertension	6.05e-07	1.75e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—POMC—hypertension	5.97e-07	1.73e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—INS—hypertension	5.94e-07	1.72e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MYC—hypertension	5.89e-07	1.71e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TGFB1—hypertension	5.87e-07	1.7e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MYC—hypertension	5.76e-07	1.67e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—EGFR—hypertension	5.76e-07	1.67e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TGFB1—hypertension	5.75e-07	1.66e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—EGFR—hypertension	5.63e-07	1.63e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MYC—hypertension	5.63e-07	1.63e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TGFB1—hypertension	5.62e-07	1.63e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—EGFR—hypertension	5.51e-07	1.6e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ALB—hypertension	5.44e-07	1.58e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—NOS3—hypertension	5.2e-07	1.51e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PIK3R1—hypertension	5.2e-07	1.51e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TP53—hypertension	4.84e-07	1.4e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PTGS2—hypertension	4.76e-07	1.38e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TP53—hypertension	4.73e-07	1.37e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TP53—hypertension	4.63e-07	1.34e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL6—hypertension	4.43e-07	1.28e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL6—hypertension	4.33e-07	1.25e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL6—hypertension	4.23e-07	1.23e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PTEN—hypertension	4.15e-07	1.2e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—AKT1—hypertension	4.08e-07	1.18e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—AKT1—hypertension	3.99e-07	1.16e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—EP300—hypertension	3.96e-07	1.15e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AKT1—hypertension	3.91e-07	1.13e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—AKT1—hypertension	2.39e-07	6.93e-06	CbGpPWpGaD
